Brief: Matinas BioPharma Enters Into At-The-Market Sales Agreement With BTIG
July 2 (Reuters) - Matinas BioPharma Holdings Inc MTNB.A :
* MATINAS BIOPHARMA - ON JULY 2, ENTERED INTO AT-THE-MARKET
SALES
AGREEMENT WITH BTIG, LLC
* MATINAS BIOPHARMA - UNDER SALES AGREEMENT CO MAY OFFER AND
SELL,
SHARES OF COMMON STOCK OF UP TO $50 MILLION
Further company coverage: MTNB.A
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Matinas BioPharma Holdings
See all newsBrief: Matinas Biopharma - May Offer Securities Up To $150 Million - SEC Filing
Brief: Matinas Biopharma Holdings Inc Keith Kucinski Resigns As CFO Effective January 17, 2026
Brief: Matinas Biopharma Holdings Inc - CFO Keith Kucinski Resigns Effective January 17, 2026 - SEC Filing
Brief: Matinas Biopharma Holdings Eric Ende Resigns As Chairman Of Matinas Biopharma
Brief: Matinas BioPharma Appoints Seasoned Biotech Leaders To Board Of Directors